InvestorsHub Logo

Advice_Needed

03/13/17 4:17 PM

#1703 RE: legalizeMJ #1701

Both the stocks you posted look promising...but both are only in phase 2 of clinical trials and are years away from being put on the market to make money. Dvax is in the final approval stage and should take the majority of money for hepatitis B vaccines after the approval of its new drug in August of this year.